サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1474934

IVドレッシングの市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2024年～2030年

IV Dressing Market Size, Share & Trends Analysis Report By Type (Transparent, Translucent), By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.53円
IVドレッシングの市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年04月03日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

IVドレッシング市場の成長と動向：

Grand View Research社の最新レポートによると、世界のIVドレッシング市場規模は2030年までに12億1,000万米ドルに達すると予測されています。

2024年から2030年までのCAGRは5.50%で拡大すると予測されています。CLABSIやCRBSIなどの血液感染症例の増加や入院患者数の増加が市場需要を押し上げるとみられます。また、老人人口の増加や慢性疾患の有病率の増加も市場成長の要因となっています。例えば、WHOによると、2015年から2050年の間に老年人口の割合は12%から22%に倍増すると予想されており、老年が慢性疾患発症の重要なリスク要因となっています。がんを含む様々な慢性疾患の治療における静脈内療法の認知度向上と採用が、市場成長の原動力になると予想されます。さまざまな企業が新しい点滴療法を発表しています。

例えば、2023年1月、Glenmark Pharmaceuticals Ltd.は、化学療法による嘔吐や吐き気を予防する点滴感染製剤AKYNZEO IVをインドで発売しました。買収など主要企業による戦略的な取り組みが市場成長に寄与すると予想されます。例えば、2022年9月、B. Braun Medical Inc.はStarboard Medicalからカテーテル固定用製品を買収しました。この取り組みにより、患者ケアの向上と点滴ドレッシングを含む同社の点滴療法製品の拡充が期待されます。さらに、主要企業による地理的拡大活動が市場成長を後押しすると予測されています。例えば、2022年1月、Smith+Nephew社は、北欧地域での製品提供を拡大するため、新たな商業拠点を発足させました。

IVドレッシング市場レポートハイライト

  • 透明製品セグメントは2023年に最大の市場シェアを占め、2024年から2030年にかけて最も速いCAGR 5.71%で成長する見込みです。
  • これは、クロルヘキシジングルコン酸塩を含浸させたゲルパッチを備えた新しい透明フィルムドレッシングの導入によるもので、カテーテルの使用期間中、部位の継続的な消毒を提供します。
  • 病院の最終用途セグメントは、高い医療投資、入院数の増加、感染症や慢性疾患の発生により、2023年に45.39%の最大売上シェアを占めました。
  • 北米は2023年に45.46%の最大売上シェアを獲得しました。これは、医療のインフラが発達していること、高齢者人口が多いこと、点滴療法の認知度と導入率が上昇していることによります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 IVドレッシング市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • IVドレッシング市場分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 IVドレッシング：タイプの推定・動向分析

  • IVドレッシング市場：タイプの変動分析
    • 透明
    • 半透明

第5章 IVドレッシング：最終用途の推定・動向分析

  • IVドレッシング市場：最終用途の変動分析

第6章 IVドレッシング市場：地域の推定・動向分析

  • 世界の地域の市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
    • イノベーター
  • ベンダー情勢
    • 3M
    • RICHARDSON HEALTHCARE, INC.
    • MEDLINE INDUSTRIES
    • SMITH &NEPHEW
    • CARDINAL HEALTH
    • CONVATEC GROUP PLC
    • PAUL HARTMANN AG
    • LOHMANN &RAUSCHER（L&R）
    • MCKESSON CORPORATION
    • MOLNLYCKE HEALTH CARE AB
    • DERMARITE INDUSTRIES, LLC
    • DEROYAL INDUSTRIES, INC.
    • BSN MEDICAL
    • DYNAREX CORPORATION.
    • KOMAL HEALTH CARE PVT. LTD.
    • SENTRY MEDICAL
    • SHANDONG DERMCOSY MEDICAL CO.,LTD.
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global I.V. Dressing Market, By Region 2018 - 2030 (USD Million)
  • Table 4. Global I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 5. Global I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 6. North America I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 8. North America I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9. U.S. I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 10. U.S. I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11. Canada I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 12. Canada I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13. Europe I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 14. Europe I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 15. Europe I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16. UK I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 17. UK I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18. Germany I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 19. Germany I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20. France I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 21. France I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22. Italy I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 23. Italy I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24. Spain I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 25. Spain I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26. Denmark I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 27. Denmark I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28. Sweden I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 29. Sweden I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30. Norway I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 31. Norway I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32. Asia Pacific I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35. Japan I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 36. Japan I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37. China I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 38. China I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39. India I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 40. India I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41. Australia I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 42. Australia I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43. Thailand I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 44. Thailand I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45. South Korea I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 46. South Korea I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47. Latin America I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 48. Latin America I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 49. Latin America I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 50. Brazil I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 51. Brazil I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52. Mexico I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 53. Mexico I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54. Argentina I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 55. Argentina I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56. MEA I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 57. MEA I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 58. MEA I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59. South Africa I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 60. South Africa I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63. UAE I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 64. UAE I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 66. Kuwait Arabia I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 I.V. Dressing market: Market snapshot
  • Fig. 9 I.V. Dressing market: Market segmentation
  • Fig. 10 I.V. Dressing market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 I.V. Dressing market driver impact
  • Fig. 16 I.V. Dressing market restraint impact
  • Fig. 17 I.V. Dressing market porter's five forces analysis
  • Fig. 18 I.V. Dressing market PESTEL analysis
  • Fig. 19 I.V. Dressing market: Type movement Analysis
  • Fig. 20 I.V dressing market: type outlook and key takeaways
  • Fig. 21 Transparent market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Translucent market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 I.V. dressing market: End use movement Analysis
  • Fig. 24 I.V. dressing market: End use outlook and key takeaways
  • Fig. 25 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global I.V. Dressing market: Regional movement analysis
  • Fig. 29 Global I.V. Dressing market: Regional outlook and key takeaways
  • Fig. 30 Global market share, by region
  • Fig. 31 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-247-2

IV Dressing Market Growth & Trends:

The global IV dressing market size is anticipated to reach USD 1.21 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 5.50% from 2024 to 2030. Increasing cases of blood infections, such as CLABSI and CRBSI, and a rising number of hospital admissions are likely to boost market demand. Also, the rising geriatric population and increasing prevalence of chronic disorders are factors contributing to market growth. For instance, according to the WHO, between 2015 and 2050, the proportion of geriatric population is expected to double from 12% to 22%, making old age a significant risk factor for developing chronic disorders. A rise in awareness and adoption of IV therapy for treating various chronic diseases including cancer is anticipated to drive market growth. Various players are launching novel IV therapies.

For instance, in January 2023, Glenmark Pharmaceuticals Ltd. launched the IV infection formulation AKYNZEO IV in India to prevent chemotherapy-induced vomiting and nausea. Strategic initiatives undertaken by top players, such as acquisitions, are expected to contribute to market growth. For instance, in September 2022, B. Braun Medical Inc. acquired catheter securement products from Starboard Medical. This initiative was anticipated to improve patient care and extend the company's IV therapy offering including IV dressing. Furthermore, geographical expansion activities by key players are projected to boost market growth. For instance, in January 2022, Smith+Nephew inaugurated a new commercial hub to increase the company's product offerings in the Nordic region.

IV Dressing Market Report Highlights:

  • The transparent product segment accounted for the largest market share in 2023 and is expected to grow at the fastest CAGR of 5.71% from 2024 to 2030
  • This is owing to the introduction of a novel transparent film dressing with a chlorhexidine gluconate-impregnated gelpatch to offer ongoing disinfection of the site throughout the duration of the catheter
  • The hospitals end-use segment held the largest revenue share of 45.39% in 2023 owing to the high healthcare investments, a rise in the number of hospitalizations, and incidences of infectious & chronic diseases
  • North America captured the largest revenue share of 45.46% in 2023. This is owing to the well-developed healthcare infrastructure, high geriatric population, and rise in the awareness & adoption of IV therapies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End Use
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
      • 1.6.1.1. Commodity flow analysis (Model 1)
      • 1.6.1.2. Approach 1: Commodity flow approach
      • 1.6.1.3. Volume price analysis (Model 2)
      • 1.6.1.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. I.V. Dressing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing cases of blood infections such as CLABSI and CRBSI
      • 3.2.1.2. Increasing hospital admission
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Complications associated with I.V. dressing
  • 3.3. I.V. Dressing Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. I.V. Dressing: Type Estimates & Trend Analysis

  • 4.1. I.V. Dressing Market: Type Movement Analysis
    • 4.1.1. Transparent
      • 4.1.1.1. Transparent market estimates and forecast, 2018 - 2030
    • 4.1.2. Translucent
      • 4.1.2.1. Translucent market estimates and forecast, 2018 - 2030

Chapter 5. I.V. Dressing: End-use Estimates & Trend Analysis

  • 5.1. I.V. Dressing Market: End-use Movement Analysis
    • 5.1.1. Hospitals
      • 5.1.1.1. Hospitals market estimates and forecast 2018 to 2030, (USD million)
    • 5.1.2. Clinics
      • 5.1.2.1. Clinics Institutes market estimates and forecast 2018 to 2030, (USD Million)
    • 5.1.3. Others
      • 5.1.3.1. Others market estimates and forecast 2018 to 2030, (USD million)

Chapter 6. I.V. Dressing Market: Regional Estimates & Trend Analysis

  • 6.1. Global Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Target Disease Prevalence
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Target Disease Prevalence
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Target Disease Prevalence
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Target Disease Prevalence
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Target Disease Prevalence
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Target Disease Prevalence
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Target Disease Prevalence
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Target Disease Prevalence
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Target Disease Prevalence
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Target Disease Prevalence
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.2. China
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.3. Japan
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Target Disease Prevalence
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Target Disease Prevalence
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Target Disease Prevalence
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.6. MEA
    • 6.6.1. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.3. South Africa
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2022
    • 7.3.4. 3M
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. RICHARDSON HEALTHCARE, INC.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. MEDLINE INDUSTRIES
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. SMITH & NEPHEW
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. CARDINAL HEALTH
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. CONVATEC GROUP PLC
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. PAUL HARTMANN AG
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. LOHMANN & RAUSCHER (L&R)
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. MCKESSON CORPORATION
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. MOLNLYCKE HEALTH CARE AB
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. DERMARITE INDUSTRIES, LLC
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. DEROYAL INDUSTRIES, INC.
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. BSN MEDICAL
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives
    • 7.3.17. DYNAREX CORPORATION.
      • 7.3.17.1. Company overview
      • 7.3.17.2. Financial performance
      • 7.3.17.3. Product benchmarking
      • 7.3.17.4. Strategic initiatives
    • 7.3.18. KOMAL HEALTH CARE PVT. LTD.
      • 7.3.18.1. Company overview
      • 7.3.18.2. Financial performance
      • 7.3.18.3. Product benchmarking
      • 7.3.18.4. Strategic initiatives
    • 7.3.19. SENTRY MEDICAL
      • 7.3.19.1. Company overview
      • 7.3.19.2. Financial performance
      • 7.3.19.3. Product benchmarking
      • 7.3.19.4. Strategic initiatives
    • 7.3.20. SHANDONG DERMCOSY MEDICAL CO.,LTD.
      • 7.3.20.1. Company overview
      • 7.3.20.2. Financial performance
      • 7.3.20.3. Product benchmarking
      • 7.3.20.4. Strategic initiatives